Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched.

Professor Stefan Neubauer is part of the Post-Hospitalisation COVID-19 Study (PHOSP-COVID) study, which has been awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). This study is one of a number of COVID-19 studies that have been given urgent public health research status by the Department of Health and Social Care.

The researchers, including Professor Ling-Pei Ho (MRC Weatherall Institute of Molecular Medicine) and Professor John Geddes (Department of Psychiatry)are part of the national consortium group of leading researchers and clinicians from across the UK to assess the impact of COVID-19 on patients’ health and their recovery.

The full story is available on the MRC Weatherall Institute of Molecular Medicine website.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

Critical six-week window to ‘reset’ blood pressure after giving birth

Home blood pressure monitors could help mothers significantly lower high blood pressure after pregnancy

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.